Suave, M. Singla, S. Gupta, and H. Singh, “Protocol for a randomized controlled study comparing the efficacy and safety of daily versus alternate day teneligliptin 20 mg in type 2 diabetes mellitus patients”, Int J Clin Trials, vol. 12, no. 2, pp. 153–162, Apr. 2025.